Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay
Journal of Parkinson’s Disease · 2023
DOI: 10.3233/jpd-213085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Ryan Arlinghaus und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Background
Synucleinopathies are a group of neurodegenerative disorders that are pathologically characterized by intracellular aggregates called Lewy bodies. Lewy bodies are primarily composed of α-synuclein (asyn) protein, which is mostly phosphorylated at serine 129 (pS129) when aggregated and therefore used as a marker for pathology. Currently commercial antibodies against pS129 asyn stain aggregates well but in healthy brains cross react with other proteins, thus making it difficult to specifically detect physiological pS129 asyn.
Objective
To develop a staining procedure that detects endogenous and physiological relevant pS129 asyn with high specificity and low background.
Methods
We used the fluorescent and brightfield in situ proximity ligation assay (PLA) to specifically detect pS129 asyn in cell culture, mouse, and human brain sections.
Results
The pS129 asyn PLA specifically stained physiological and soluble pS129 asyn in cell culture, mouse brain sections, and human brain tissue without significant cross-reactivity or background signal. However, this technique was not successful in detecting Lewy bodies in human brain tissue.
Conclusion
We successfully developed a novel PLA method that can, in the future, be used on in vitro and in vivo samples as a tool to explore and better understand the cellular localization and function of pS129 asyn in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA.
- Molecular Neuropathology Section, Laboratory of Neurogenetics, National Institutes on Aging, NIH, Bethesda, MD, USA.
- Division of Neuroscience, National Institute on Aging, NIH, Bethesda, MD, USA.
Förderung
- Intramural NIH HHS
Zitieren
APA
Arlinghaus, R., Iba, M., Masliah, E., Cookson, M. R., & Landeck, N. (2023). Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-213085
Vancouver
Arlinghaus R, Iba M, Masliah E, Cookson MR, Landeck N. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-213085
BibTeX
@article{Arlinghaus2023,
author = {Arlinghaus, Ryan and Iba, Michiyo and Masliah, Eliezer and Cookson, Mark R and Landeck, Natalie},
title = {Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay},
journal = {Journal of Parkinson’s Disease},
year = {2023},
doi = {10.3233/jpd-213085}
}
EUVIMED